Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalon GloboCare (ALBT) Gains from Sales and Divestitures (2017 - 2025)

Avalon GloboCare filings provide 9 years of Gains from Sales and Divestitures readings, the most recent being $80000.0 for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 1.78% to $80000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $80000.0, a 1.78% decrease, with the full-year FY2025 number at $80000.0, down 1.78% from a year prior.
  • Gains from Sales and Divestitures hit $80000.0 in Q4 2025 for Avalon GloboCare, roughly flat from $80000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $651668.0 in Q3 2021 to a low of $19137.0 in Q1 2023.
  • Median Gains from Sales and Divestitures over the past 5 years was $179998.0 (2023), compared with a mean of $236514.7.
  • Biggest five-year swings in Gains from Sales and Divestitures: crashed 95.73% in 2021 and later increased 0.97% in 2022.
  • Avalon GloboCare's Gains from Sales and Divestitures stood at $85750.0 in 2021, then increased by 0.97% to $86583.0 in 2022, then soared by 107.89% to $179998.0 in 2023, then plummeted by 54.75% to $81450.0 in 2024, then decreased by 1.78% to $80000.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $80000.0 (Q4 2025), $80000.0 (Q3 2025), and $80000.0 (Q2 2025) per Business Quant data.